Table 1.
Study (years) | Species (Sex, n = experimental/control group) | Weight | Model (method) | Anesthetic | Treatment group (method to GB) | Control group | Outcome index (time) | Intergroup differences |
---|---|---|---|---|---|---|---|---|
Zhuang et al., 2017 (1) | SD rats (male, 20/20) | 220–260 g | Block LAD for 30 min then reperfusion | Urethane (650 mg/kg) | Intraperitoneal injection GB (60 mg/kg*d), once a day, for 7 days, after establishing model | Intraperitoneal injection isasteric normal saline, once a day, for 7 days, after establishing model |
|
|
Xiong and Wei, 2015 (2) | SD rats (male, 20/20) | 250–270 g | Block of LAD for 30 min then reperfusion for 48 h | 7% chloral hydrate | Gavaged with GB (60 mg/kg*d), once a day, for 7 days, before establishing model | Gavaged with isasteric normal saline, once a day, for 7 days, before establishing model |
|
|
Cao et al., 2016 (3) | SD rats (male/female, 10/10) | 200–240 g | Block LAD for 30 min then reperfusion for 2 h | Pentobarbital sodium (45 mg/kg) | Tail intravenous injection GB (8 mg/kg), 1 h before establishing model | Tail intravenous injection isasteric normal saline, 1 h before establishing model |
|
|
Meng, 2017 (4) | SD rats (male, 20/20) | 220–260 g | Block LAD for 30 min then reperfusion | Urethane (650 mg/kg) | Intraperitoneal injection GB (60 mg/kg*d), once a day, for 7 days, after establishing model | Intraperitoneal injection isasteric normal saline, once a day, for 7 days, after establishing model |
|
|
Bai et al., 2016 (5) | SD rats (male, 20/20) | 220–260 g | Block LAD for 30 min then reperfusion | Urethane (650 mg/kg) | Intraperitoneal injection GB (60 mg/d), once a day, for 7 days, after establishing model | Intraperitoneal injection isasteric normal saline, once a day, for 7 days, after establishing model |
|
|
Chai et al., 2018 (6) | SD rats (male, 20/20) | 220–260 g | Block LAD for 30 min then reperfusion for 1 h | Urethane (1 g/kg) | Intraperitoneal injection GB (60 mg/kg*d), once a day, for 7 days, before establishing model | Intraperitoneal injection (18 mg/kg*d) normal saline, once a day, for 7 days, before establishing model |
|
|
Yang et al., 2018 (7) | SD rats (male, 7/7) | 180–220 g | Block LAD for 30 min then reperfusion for 2 h | 10% chloral hydrate | Intraperitoneal injected with GB (60 mg/kg), 30 min before establishing model | Intraperitoneal injection isasteric normal saline, 30 min before establishing model |
|
|
Jiao et al., 2002 (8) | Wistar rats (male, 12/12) | 250–300 g | Block LAD for 30 min then reperfusion for 3 h | Urethane (1 g/kg) | Intraperitoneal injection GB (5 mg/kg), 25 and 10 min before establishing model respectively | Intraperitoneal injection isasteric normal saline, 25 and 10 min before establishing model respectively |
|
|
Rioufol et al., 2003 (9) | Farm pigs (male/female, 6/7) | 27–28 Kg | Block LAD for 10 min then reperfusion for 3 h | Pentobarbital (15 mg/kg) | Intravenous injection GB (0.3 mg/kg), 48 h and 24 h before establishing model | Intravenous injection isasteric normal saline, 48 h and 24 h before establishing model |
|
|
Pei et al., 2015 (10) | Wistar rats (male, 10/12) | 280–400 g | Block LAD for 5 min then reperfusion for 10 min | pentobarbitalsodium (4.5 mg/kg) | Intravenous injection GB (15 mg/kg), 10 min before establishing model | Intravenous injection isasteric normal saline, 10 min before establishing model |
|
|
Hao et al., 2009 (11) | SD rats (male, 7/7) | 220–250 g | Langendorff Model 30 min stabilization I/R (30 min/120 min) | Pentobarbital (150 mg/kg) | GB (10uM), for 10 min before ischemia | No treatment |
|
|
Hao and Dong, 2017 (12) | SD rats (male, 10/10) | 350–500 g | Langendorff Model 30 min, I/R (30 min/60 min) | 1% pentobarbital sodium | GB (10 μmol/L), first 10 min of reperfusion | No treatment |
|
|
Hao et al., 2013 (13) | SD rats (male, 8/8) | 200–250 g | Langendorff Model 30 min stabilization I/R (20 min/40 min) | 1% pentobarbital sodium | GB (10 μmol/L), for 10 min before ischemia | No treatment |
|
|
Hao et al., 2016 (14) | SD rats (male, 10/10) | 350–500 g | Langendorff Model 30 min stabilization I/R (30 min/90 min) | 1% pentobarbital sodium | GB (10 μmol/L), first 10 min of reperfusion | No treatment |
|
|
Liebgott et al., 2000 (15) | Wistar rats (male, 12/13) | 300–350 g | Langendorff Model 30 min stabilization, low-flow ischemia/I/R (10 min/30 min/60 min) | Pentobarbital sodium (50 mg/kg) | GB (0.05 μg/ml), last 10 min of perfusion, entire period of low-flow ischemia and the first 10 min of reperfusion | No treatment |
|
|
Zhao et al., 2014 (16) | SD rats (male/female, 10/10) | 200–250 g | Langendorff Model 30 min stabilization I/R (20 min/40 min) | 10% chloral hydrate | GB (10 μmol/L), for 10 min before ischemia | No treatment |
|
|
Zhang et al., 2005 (17) | Wistar rats (male/female, 8/8) | 200–250 g | Langendorff Model 30 min stabilization, I/R (15 min/30 min) | 20% Urethane (1.0 g/kg) | GB (10 μmol/L), for 10 min before ischemia | No treatment |
|
|
Billottet et al., 2005 (18) | Wistar rats (male, 12/12) | 300–350 g | Langendorff Model 30 min stabilization, low-flow ischemia/I/R (20 min/20 min/60 min) | Pentobarbital sodium (50 mg/kg) | GB (0.05 μg/ml), last 10 min of perfusion, entire period of low-flow ischemia and the first 10 min of reperfusion | No treatment |
|
|
Zhang et al., 2018 (19) | SD rats (male, 8/8) | 250–300 g | Block LAD for 40 min then reperfusion for 2 h | Chloral hydrate (300 mg/kg) | Intraperitoneal injection GB (32 mg/kg*d), once a day, for 7 days, before establishing model | Intraperitoneal injection isasteric normal saline, once a day, for 7 days, after establishing model |
|
|
AAI, Area at infarct; AAR, area at risk; AST, aspartate transaminase; Bax, Bcl-2-Associated X; Bcl-2, B-cell lymphoma-2; CAT, catalase; CK, creatine kinase; EF, ejection fraction; ErK, extracellular signal-regulated kinase; FS, fractional shorting; GSH-Px, glutathione peroxidase; HR, heart rate; IL-6, interleukin-6; JNK, c-Jun N-terminal kinase; LAD, left anterior descending coronary artery; LVA, left ventricular area; LVDP, left ventricular developed pressure; LVEDP, left ventricular end diastolic pressure; LDH, lactate dehydrogenase; LVIDd, left ventricular internal diameter at end-diastole; LVIDs, left ventricular internal diameter at end-systole; LVSP, Left ventricular systolic pressure; MDA, malondialdehyde; MPO, myeloperoxidase; ±dp/dtmax, Maximal rate of the increase/decrease of left ventricular pressure; p38MAPK, p38 mitogen-activated protein kinase; NF-kB, Nuclear factor-kappa B; PMNs, polymorphonuclears; RPP, rate pressure pruduct; SOD, superoxide dismutase; SV, stroke volume; SD rats, Sprague-Dawley; TNF-α, tumor necrosis factor-α.